Press Releases
December 5, 2005
Xanodyne Pharmaceuticals Moves Headquarters
For Immediate Release
Newport, KY – December 5, 2005 – Xanodyne Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management, today announced that it has relocated its headquarters to a new facility in Newport, KY. The 86,000 sq ft headquarters are located on the southern bank of the Ohio River, directly across from Cincinnati. The address of the new offices is:
One Riverfront Place
Newport, KY 41071-4563
“This is another step forward for Xanodyne. Not only was our new facility fitted-out for a specialty pharmaceutical company but, it also incorporates enough space to meet our growth ambitions for the next several years” said William Nuerge, CEO of Xanodyne.
About Xanodyne
Xanodyne Pharmaceuticals, Inc. is a privately owned, fully integrated, branded specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management. The company, located in the greater Cincinnati area, has a nationwide sales force and currently markets numerous pharmaceutical products. More information regarding Xanodyne can be accessed at www.xanodyne.com.